{
    "id": "correct_subsidiary_00047_1",
    "rank": 28,
    "data": {
        "url": "https://pink.citeline.com/PS074196/GSKs-Stiefel-Adds-PsoriasisAtopical-Dermatitis-Candidate-In-Licensing-Deal",
        "read_more_link": "",
        "language": "en",
        "title": "GSK’s Stiefel Adds Psoriasis/Atopical Dermatitis Candidate In Licensing Deal",
        "top_image": "http://pink.citeline.com/-/media/icons/2023/pink_citeline_158.png?rev=cb261f74c0d2448085ca73945c77ccaf",
        "meta_img": "http://pink.citeline.com/-/media/icons/2023/pink_citeline_158.png?rev=cb261f74c0d2448085ca73945c77ccaf",
        "images": [
            "https://pink.citeline.com/-/media/icons/2023/pink-sheet_domain_pos_rgb.png?rev=1dd7601600144594a8ec74ff6df8b547",
            "https://pink.citeline.com/-/media/icons/2023/pink_citeline_greyscale.png?rev=6b1ffa05a8e647db9ad3e9ec68a82115",
            "https://pink.citeline.com/dist/img/arrow.png",
            "https://pink.citeline.com/-/media/icons/2023/citeline_logo_footer.png?rev=317781d93d4a4821951866c7e7ab631c"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2012-05-31T21:13:56+00:00",
        "summary": "",
        "meta_description": "For about $34 million, Stiefel gets development and commercialization rights in most of the world to a novel, non-steroidal, topical anti-inflammatory compound in Phase II.",
        "meta_lang": "",
        "meta_favicon": "/-/media/icons/2023/favicon-regulatory.png?rev=786493faaab643039eba9fc8a0d3d3ea",
        "meta_site_name": "Pink Sheet",
        "canonical_link": "http://pink.citeline.com/PS074196/GSKs-Stiefel-Adds-PsoriasisAtopical-Dermatitis-Candidate-In-Licensing-Deal",
        "text": "Please make sure all fields are completed.\n\nPlease make sure you have filled out all fields\n\nPlease make sure you have filled out all fields\n\nPlease enter a valid e-mail address\n\nPlease enter a valid Phone Number\n\nAsk your question to our analysts\n\nCancel\n\nPlease make sure all fields are completed.\n\nPlease enter a valid e-mail address\n\nPlease make sure you have filled out all fields\n\nPlease make sure you have filled out all fields\n\nSubject: GSK’s Stiefel Adds Psoriasis/Atopical Dermatitis Candidate In Licensing Deal\n\nAdd a personalized message to your email\n\nCancel"
    }
}